LAVA Therapeutics NV (LVTX)
3.06
-0.03
(-0.97%)
USD |
NASDAQ |
May 13, 16:00
3.08
+0.02
(+0.65%)
After-Hours: 20:00
LAVA Therapeutics Profit Margin (Quarterly): -1.84K% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.84K% |
| September 30, 2023 | -16.67K% |
| June 30, 2023 | -247.1% |
| March 31, 2023 | -1.14K% |
| December 31, 2022 | -565.0% |
| September 30, 2022 | 6.13% |
| June 30, 2022 | -1.73K% |
| March 31, 2022 | -961.1% |
| Date | Value |
|---|---|
| December 31, 2021 | -771.0% |
| September 30, 2021 | -330.9% |
| June 30, 2021 | -744.2% |
| March 31, 2021 | -1.97K% |
| December 31, 2020 | -172.6% |
| September 30, 2020 | -406.3% |
| June 30, 2020 | -586.0% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-16.67K%
Minimum
Sep 2023
6.13%
Maximum
Sep 2022
-1.88K%
Average
-744.2%
Median
Jun 2021
Profit Margin (Quarterly) Benchmarks
| uniQure NV | -773.3% |
| ProQR Therapeutics NV | -172.1% |
| Merus NV | -436.8% |
| argenx SE | -15.36% |
| Pharming Group | -22.39% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -63.41% |
| Return on Assets | -34.18% |
| Return on Invested Capital | -59.01% |
| Gross Profit Margin (Quarterly) | 56.37% |
| Operating Margin (Quarterly) | -1.54K% |
| Return on Net Operating Assets | -138.3% |